Skip to main content

Year: 2021

SPEY RESOURCES CORP. ANNOUNCES BOARD CHANGE

Vancouver, British Columbia, Dec. 13, 2021 (GLOBE NEWSWIRE) — Spey Resources Corp. (CSE: SPEY) (OTC: SPEYF) (FRA: 2JS) (“Spey” or the “Company“), is pleased to announce that Lawrence Hay has joined the Board of Directors effective December 13, 2021. Mr. Hay has extensive experience providing corporate development services and consultation to both private and public sector clients, particularly those within the lithium industry. Mr. Hay studied at Vancouver Community College, obtaining his Red Seal certification in 2012, while apprenticing and developed a significant interest in the lithium market due to the growing demand in electric vehicles. Mr. Hay has since been working within the automotive industry for the past 10 years before he proceeded with the incorporation and operation of Tech One Lithium Resources...

Continue reading

SMC Moves to establish ESOP

Point Roberts, WA, Dec. 13, 2021 (GLOBE NEWSWIRE) — SMC Entertainment, Inc. (“SMC” or the “Company”) (OTC: SMCE) and its subsidiary Genesis Financial, Inc. (“Genesis”), a diversified financial services company with a focus on fintech-powered wealth management advisory services, are pleased to announce that consistent with their intentions as stated in the definitive agreements, have engaged attorneys to prepare an Executive and Employee Share Option Plan (ESOP) to provide the basis for a model to reward and remunerate advisors, executives and shareholders as the case may be. “In a financial services firm, Human Capital is the single greatest asset, and it is vital that we have the ability to provide ongoing incentives and rewards to our greatest asset; the people that work for us whether they are advisors or executive management.”...

Continue reading

Pulse Seismic Inc. Provides 2021 Sales Update and Announces Addition of Director of Geoscience

CALGARY, Alberta, Dec. 13, 2021 (GLOBE NEWSWIRE) — Pulse Seismic Inc. (TSX:PSD) (OTCQX:PLSDF) (“Pulse” or the “Company”) is pleased to report the completion of the $17.0 million seismic data licensing contract that was signed and previously announced in May 2021. The licence was for 3D seismic data located in a liquids rich fairway in the west shale basin with multi-zone potential in Central Alberta. As previously disclosed, on signing the deal in May, the Company delivered $7.3 million of seismic data, with the remainder of the data agreed to be selected by the customer at any time before April 15, 2022. Today the remaining data was delivered to the customer resulting in the recognition of an additional $9.7 million of seismic data sales revenue in 2021. “I am pleased to announce that the fulfillment of this contract in 2021 will...

Continue reading

Alamos Gold Announces Exercise of Red Pine Exploration Inc. Warrants

TORONTO, Dec. 13, 2021 (GLOBE NEWSWIRE) — Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) today announced the exercise of 5,299,525 common share purchase warrants (the “Warrants”) with an exercise price of CDN$0.50 per common share of Red Pine Exploration Inc. (“Red Pine”) in exchange for 5,299,525 common shares (the “Exercise”), representing approximately 4.83% of the outstanding common shares of Red Pine. Immediately prior to the Exercise, Alamos had beneficial ownership of, or control and direction over, 17,414,858 common shares and 5,299,525 Warrants of Red Pine. Assuming exercise of the 5,299,525 Warrants, Alamos had beneficial ownership of, or control and direction over 22,714,383 common shares or 19.75% of the issued and outstanding shares of Red Pine on a partially diluted basis. As a...

Continue reading

Update on Novartis Agreement

NEW YORK, Dec. 13, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, was notified today by Novartis that it has chosen to terminate the agreement with Mesoblast prior to closing. Mesoblast remains highly focused on executing on our short term objective to bring remestemcel-L to market for patients with acute respiratory distress syndrome (ARDS) due to COVID-19. The observed mortality reduction with remestemcel-L in patients aged under 65 in the completed COVID ARDS trial, despite having missed the primary endpoint, is considered by Mesoblast to be a sufficiently strong signal to support pursuing an emergency use authorization (EUA), the most direct path to market. Mesoblast is preparing to initiate a pivotal Phase 3 trial that may support...

Continue reading

Mercado Libre announces the acquisition of Redelcom to strengthen its strategy in payment systems

Mercado Libre acquired the entire company in order to further strengthen its operation in Chile in the payment methods sector, especially in the physical world for SMEs, and to continue fulfilling its purpose of democratizing commerce and finance in the country. This is Mercado Libre’s first purchase in the region in payment systems, which strengthens the business position of its Mercado Pago unit, the largest fintech in Latin America.SANTIAGO, Chile, Dec. 13, 2021 (GLOBE NEWSWIRE) — Mercado Libre, a technology firm and the largest e-commerce company in Latin America, announced the acquisition of Redelcom, a Chilean company that has been operating since 2010 as a payment services provider and that in October 2019 began offering point-of-sale (POS) terminals with the latest technology to retailers. Mercado Libre seeks...

Continue reading

Kairous Acquisition Corp. Limited Pricing of $75 Million Initial Public Offering

Malaysia, Dec. 13, 2021 (GLOBE NEWSWIRE) — Kairous Acquisition Corp. Limited (the “Company”), a newly organized blank check company incorporated as a Cayman Islands business company and led by Chief Executive Officer, Joseph Lee, today announced the pricing of its initial public offering of 7,500,000 units at an offering price of $10.00 per unit, with each unit consisting of one ordinary share, one half of one redeemable warrant, and one right to receive one-tenth (1/10) of an ordinary share. Each whole warrant will entitle the holder thereof to purchase one ordinary share, and each ten rights entitle the holder thereof to receive one ordinary share. The exercise price of the warrants is $11.50 per full share. The units are expected to trade on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “KACLU” beginning on December...

Continue reading

Landec Corporation Announces Sale of Curation Foods’ Fresh Packaged Salads and Vegetables Business for $73.5 Million in Cash

Strategic sale results in a CDMO-focused company aligned with attractive growth categories and end marketsNet proceeds from the sale will be allocated towards debt pay down, resulting in significant deleveragingAnnounces fiscal second quarter earnings call on January 5, 2022 SANTA MARIA, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) — Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company focused on its growing Lifecore Biomedical (“Lifecore”) business – a fully integrated contract development and manufacturing organization (“CDMO”) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials – today announced that it has completed the sale of its Curation Food’s fresh packaged salads and...

Continue reading

Agios Presents Mitapivat Long-term Extension Data Demonstrating Durability of Hemoglobin Response and Transfusion Burden Reduction in Adults with Pyruvate Kinase (PK) Deficiency at 63rd ASH Annual Meeting and Exposition

– Additional Data Presented at ASH Support the Potential of Mitapivat to Improve Ineffective Erythropoiesis and Iron Overload and Stabilize Bone Mineral Density in PK Deficiency Patients – – Mitapivat Is Under Regulatory Review in the U.S. and EU as a Potential Treatment for Adults with PK Deficiency – – Agios to Host Investor Webcast on Dec. 14, 2021, at 7:30 a.m. ET – CAMBRIDGE, Mass., Dec. 13, 2021 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat genetically defined diseases, today reported new data from the ongoing long-term extension study assessing the duration of effects of mitapivat on hemoglobin response and transfusion burden reduction in adults with pyruvate kinase (PK) deficiency who had participated in one of the pivotal studies, ACTIVATE and ACTIVATE-T,...

Continue reading

Global Water Resources Signs Letter of Intent to Acquire Farmers Water Co. in Pima County, Arizona

SAHUARITA, Ariz., Dec. 13, 2021 (GLOBE NEWSWIRE) — Global Water Resources, Inc. (NASDAQ: GWRS), (TSX: GWR), an Arizona-based water resource management company, has signed a Letter of Intent to acquire Farmers Water Co., a subsidiary of Farmers Investment Co. (FICO), located in Pima County, Arizona. The acquisition, if completed, would add approximately 3,300 active water service connections in Sahuarita and surrounding unincorporated Pima County to the Global Water family of companies. The primarily residential connections are in close proximity to the service area of Global Water’s recently acquired Las Quintas Serenas, Francesca, Mirabell, and Red Rock water companies. The next steps in the acquisition process include the completion of due diligence, execution of definitive agreements, and other customary conditions and approvals. “We...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.